1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Unilever PLC
  6. News
  7. Summary
    ULVR   GB00B10RZP78

UNILEVER PLC

(ULVR)
  Report
Delayed London Stock Exchange  -  05/18 11:35:30 am EDT
3635.00 GBX   -0.85%
05/19UNILEVER PLC : Ex-dividend day for interim dividend
FA
05/18UNITED WE STAND : Unilever Supports Systemic Change for LGBTQI+ Communities
BU
05/18Indian Indices Close in Red Midweek; Power Grid Corporation of India Drops 5%
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Unilever Looking to Reposition Portfolio After GSK Consumer Healthcare Approach -- Update

01/17/2022 | 03:22am EDT

By Kyle Morris


Unilever PLC said Monday that it has decided to expand its presence in higher-growth categories after it made an approach for GSK Consumer Healthcare over the weekend that could potentially be worth $68 billion.

The Anglo-Dutch consumer-goods group said that, following a review process, it has concluded that its future strategic direction lies in materially expanding its presence in higher-growth categories such as health, beauty, and hygiene. Such categories offer higher rates of sustainable market growth, with opportunities to drive growth through investment and innovation, and through leveraging the company's presence in emerging markets, it said.

As part of the plan, major acquisitions would be combined with the accelerated divestment of lower-growth brands and businesses.

Consumer health has good potential for synergies and GSK Consumer Healthcare would be a strong strategic fit, the company said. The acquisition of GSK Consumer Healthcare would create scale and a growth platform for the combined portfolio in the U.S., China, and India, with further opportunities in other emerging markets.

On Jan. 15, Unilever said it had approached GlaxoSmithKline PLC and Pfizer Inc. about a deal for their consumer-healthcare joint venture.

A major initiative to enhance performance will be announced later this month, the company said.


Write to Kyle Morris at kyle.morris@dowjones.com


(END) Dow Jones Newswires

01-17-22 0322ET

Stocks mentioned in the article
ChangeLast1st jan.
GLAXOSMITHKLINE CONSUMER HEALTHCARE PAKISTAN LIMITED -0.79% 232 End-of-day quote.-3.76%
GLAXOSMITHKLINE PLC -0.68% 1770.2 Delayed Quote.10.18%
ON SEMICONDUCTOR CORPORATION -4.56% 55.83 Delayed Quote.-17.80%
PFIZER, INC. -1.83% 50.4 Delayed Quote.-14.65%
UNILEVER PLC -0.85% 3635 Delayed Quote.-8.10%
All news about UNILEVER PLC
05/19UNILEVER PLC : Ex-dividend day for interim dividend
FA
05/18UNITED WE STAND : Unilever Supports Systemic Change for LGBTQI+ Communities
BU
05/18Indian Indices Close in Red Midweek; Power Grid Corporation of India Drops 5%
MT
05/17WALL STREET STOCK EXCHANGE : Finding the tipping point
05/17MARKETSCREENER'S WORLD PRESS REVIEW : May 17, 2022
05/17SocGen Downgrades Unilever To Sell From Buy, Cuts PT
MT
05/17Unilever, Uber, Zurich Call For 2035 Ban On Combustion Engines In Europe
MT
05/17ANALYST RECOMMENDATIONS : AMD, CarMax, Gilead, J.B. Hunt, Vodafone...
05/17FTSE 100 lags European peers on strong pound
RE
05/17India's WPI inflation at 17-year high threatens small businesses
RE
More news
Analyst Recommendations on UNILEVER PLC
More recommendations
Financials
Sales 2022 57 559 M 60 404 M 60 404 M
Net income 2022 5 626 M 5 904 M 5 904 M
Net Debt 2022 23 919 M 25 101 M 25 101 M
P/E ratio 2022 20,5x
Yield 2022 3,96%
Capitalization 109 B 115 B 115 B
EV / Sales 2022 2,32x
EV / Sales 2023 2,23x
Nbr of Employees 148 012
Free-Float 95,5%
Chart UNILEVER PLC
Duration : Period :
Unilever PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends UNILEVER PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 42,86 €
Average target price 47,17 €
Spread / Average Target 10,1%
EPS Revisions
Managers and Directors
Alan Jope Chief Executive Officer & Executive Director
Graeme David Pitkethly Chief Financial Officer & Executive Director
Nils Smedegaard Andersen Chairman
Richard Slater Chief Research & Development Officer
Nitin Paranjpe Chief Operating, Transformation & People Officer
Sector and Competitors
1st jan.Capi. (M$)
UNILEVER PLC-8.10%114 798
PROCTER & GAMBLE COMPANY-5.44%371 123
THE ESTÉE LAUDER COMPANIES INC.-34.47%86 685
HINDUSTAN UNILEVER LIMITED-2.93%68 099
COLGATE-PALMOLIVE COMPANY-7.70%66 005
RECKITT BENCKISER GROUP PLC-0.82%56 074